← Back to Search

Antiplatelet Agent

ASA 81mg for Colorectal Cancer

Phase 2

Waitlist Available

Led By Robert Hilsden

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at enrollment

Awards & highlights

Study Summary

This trial is testing whether a real-world chemoprevention agent (CPA) intervention (3-months of daily low-dose acetylsalicylic (ASA)) is feasible in participants at increased risk for colorectal cancer (CRC).

Eligible Conditions

Colorectal Cancer
Colorectal Adenomas
Colorectal Polyps

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to ASA over 90 days

Adherence to at least 50 percent of total prescribed dose

Measurement of Adverse Events

+1 more

Secondary outcome measures

Factors related to uptake and adherence to ASA

Aspirin

Factors related to uptake and adherence to ASA using measurement of self efficacy

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: ASA 81mgExperimental Treatment1 Intervention

Acetylsalicylic acid delayed release tablets (81mg), single tablet taken once per day for 90 days.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Canadian Cancer Society (CCS)OTHER

78 Previous Clinical Trials

37,645 Total Patients Enrolled

University of CalgaryLead Sponsor

791 Previous Clinical Trials

868,634 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,341 Previous Clinical Trials

26,452,613 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment recruiting participants at the moment?

"Clinicaltrials.gov indicates that this research project is not currently enrolling patients, as it was posted on July 1st 2022 and last modified May 27th 2022. Notwithstanding, there are still 1137 different clinical trials actively searching for participants at the present time."

Answered by AI

Does this research project accept participants under the age of 30?

"This trial requires patients to be within the age range of 50 and 59. There are 44 trials for those below 18, and 1122 trials for people 65 or above."

Answered by AI

What are the primary aims of this clinical experiment?

"This clinical trial will be assessed over a period of seven days, with the principal aim to ensure adherence to ASA for 90 days. Ancillary outcomes include evaluation of self-efficacy (utilizing NIH Self-Efficacy Questionnaire), consideration of beliefs and values concerning chemoprevention medicines (as measured via Beliefs about Medicines questionnaire) and analysis of knowledge related to taking preventative medication (using Chemoprevention Questionnaires)."

Answered by AI

What are the eligibility criteria for taking part in this medical experiment?

"To be considered for inclusion in this trial, patients must possess adenomatous polyps and their age should fall between 50-59 years old. The study is aiming to enroll approximately 100 participants."

Answered by AI

Has this treatment earned the endorsement of government regulators?

"Although the data supporting efficacy of this treatment is limited, safety has been adequately researched and our team at Power consequently assigns a rating of 2."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study

2022. "The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05402124.

All > Durlaza